Advanced search
Publication Cover
Scandinavian Journal of Urology and Nephrology Volume 37, 2003 - Issue 6
Submit an article Journal homepage
36
Views
21
CrossRef citations to date
0
Altmetric
Article

Non‐systematic screening for prostate cancer in Sweden
Survey from the National Prostate Cancer Registry

Pär Stattin Department of Urology and Andrology, Umeå University Hospital, Umeå, SwedenCorrespondence[email protected]
,
Robert Johansson Oncological Centre, Umeå University Hospital, Umeå, Sweden
,
Jan‐Erik Damber Departments of Urology, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden
,
Magnus Hellström Karolinska Hospital, Stockholm, Sweden
,
Jonas Hugosson Departments of Urology, Sahlgrenska Academy at Göteborg University, Göteborg, Sweden
,
Rolf Lundgren Helsingborg Hospital, Helsingborg, Sweden
,
Eberhard Varenhorst Department of Surgery and Urology, Norrköping Hospital, Norrköping, Sweden
&
Jan‐Erik Johansson Department of Clinical Medicine, Division of Urology and Center for Assessment of Medical Technology, Örebro University Hospital, Örebro, Sweden
 show all
Pages 461-465 | Received 31 Mar 2003, Accepted 04 Jun 2003, Published online: 09 Jul 2009

References

  • Hsing AW, Tsao L, Devesa SS. International trends and patterns of prostate cancer incidence and mortality. Int J Cancer 2000; 85: 60–7.
  • Sandblom G, Holmberg L, Damber JE, Hugosson J, Johansson JE, Lundgren R, et al. Prostate-specific antigen as surrogate for characterizing prostate cancer subgroups. Scand J Urol Nephrol 2002; 36: 106–12.
  • www.oc.umu.se.
  • Holmberg L, Bill-Axelson A, Helgesen F, Salo JO, Folmerz P. Haggman M, et al. A randomized trial comparing radical pro statectomy with watchful waiting in early prostate cancer. N Engl J Med 2002; 347: 781–9.
  • Etzioni R, Legler JM, Feuer EJ, Merrill RM, Cronin KA, Hankey BF. Cancer surveillance series: interpreting trends in prostate cancer. Part III. Quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality. J Natl Cancer Inst 1999; 91: 1033–9.
  • Oliver SE, Gunnell D, Donovan JL. Comparison of trends in prostate-cancer mortality in England and Wales and the USA. Lancet 2000; 355: 1788–9.
  • Lu-Yao G, Albertsen PC, Stanford It, Stukel TA, Walker-Corkery ES, Barry MJ. Natural experiment examining impact of aggressive screening and treatment on prostate cancer mortality in two fixed cohorts from Seattle area and Connecticut. Br Med J 2002; 325: 740.
  • Wasson JH, Bubolz TA, Yao GL, Barry MJ. Prostate biopsies in men with limited life expectancy. Eff Clin Pract 2002; 5: 137–42.
  • Donovan JL, Frankel SJ, Neal DE, Hamdy FC. Screening for prostate cancer in the UK. Seems to be creeping in by the back door. Br Med J 2001; 323: 763–4.
  • Pilebro B, Johansson R, Damber L, Damber JE, Stattin P. Population-based study of prostate-specific antigen testing and prostate cancer detection in clinical practice in northern Sweden. Scand J Urol Nephrol 2003; 37: 210–2.
  • Union Internationale Contre le Cancer. TNM classifica-tion of malignant tumours, 4th edn. Berlin: Union Internationale Contre le Cancer, 1992.
  • Legler JM, Feuer EJ, Potosky AL, Merrill RM, Kramer BS. The role of prostate-specific antigen (PSA) testing patterns in the recent prostate cancer incidence decline in the United States. Cancer Causes Control 1998; 9: 519–27.
  • Treagust J, Morkane T, Speakman M. Estimating a population's needs for the treatment of lower urinary tract symptoms in men: what is the extent of unmet need? J Publ Health Med 2001; 23: 141–7.
  • Platz EA, Smit E, Curhan GC, Nyberg LM, Giovannucci E. Prevalence of and racial/ethnic variation in lower urinary tract symptoms and noncancer prostate surgery in U.S. men. Urology 2002; 59: 877–83.
  • Verhamme KM, Dieleman JP, Bleumink GS, van der Lei J, Sturkenboom MC, Artibani W, et al. Incidence and prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia in primary care—the Triumph project. Eur Urol 2002; 42: 323–8.
  • Egevad L. Reproducibility of Gleason grading of prostate cancer can be improved by the use of reference images. Urology 2001; 57: 291–5.
  • TNM Classification of Malignant Tumours. Fourth edn, 2nd rev, 1992.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.